Copertina

Turning Limitations Into Insights: The Path Forward for COPD and Cardiovascular Risk Research

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Paula Rodriguez‐Miguelez, Youngdeok Kim
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	Respirology
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

COPD is associated with increased cardiovascular disease risk independent of phenotype
di: Kolton Cobb, et al.
Pubblicazione: (2024)

Limitations of Self‐Reported Data in Evaluating COPD Phenotypes and Cardiovascular Risk
di: Ibrahim Nagmeldin Hassan
Pubblicazione: (2025)

Management of COPD With Cardiovascular Risk in Asia: A Review by the Asian Pacific Society of Respirology COPD Assembly
di: Chin Kook Rhee, et al.
Pubblicazione: (2025)

Rebranding COPD Care and Research in the 21st Century
di: Joan B. Soriano, et al.
Pubblicazione: (2025)

Asthma‐COPD overlap and asthma progressing to COPD: A complementary perspective
di: Christine F. McDonald, et al.
Pubblicazione: (2024)

Missing Millions With COPD
di: John R. Hurst
Pubblicazione: (2025)

Breathless and heart broken in COPD
di: John R. Hurst
Pubblicazione: (2024)

COPD: The forgotten cardiovascular risk
di: Belinda Cochrane
Pubblicazione: (2024)

Asthma‐COPD overlap and asthma progressing to COPD: Are we using the right diagnostic approaches and pathways?
di: Elvis Malcolm Irusen, et al.
Pubblicazione: (2024)

Transforming recruitment to clinical trials in COPD
di: Tanya Patrick, et al.
Pubblicazione: (2024)

Challenges in the Management of Asthma and COPD in the Asia‐Pacific Region
di: Fanny Wai San Ko, et al.
Pubblicazione: (2026)

Is there a role for chest wall mobilization in the management of COPD?
di: Annemarie L. Lee, et al.
Pubblicazione: (2024)

Pulmonary function testing in COPD: Anchoring clinical relevance
di: Bruce R. Thompson
Pubblicazione: (2024)

Validation and Further Analysis of the COPD Exacerbation Recognition Tool ( CERT )
di: Xiangju Xing, et al.
Pubblicazione: (2025)

Early Diagnosis of COPD —How Can we Do Better?
di: Shawn D. Aaron
Pubblicazione: (2025)

Form Is Function: Predicting COPD Outcomes With Respiratory Muscle Dysfunction
di: Bartolome R. Celli
Pubblicazione: (2025)

Airway Mucus Plugs in COPD : A Potential Treatable Trait
di: Naoya Tanabe
Pubblicazione: (2025)

An Important Step Towards Better Health Management for People With COPD
di: Brian J. Smith
Pubblicazione: (2026)

Enhancing COPD Care for Women: A Predictive Tool for Palliative Needs
di: Syed Ahmar Shah
Pubblicazione: (2025)

High Airway‐To‐Vessel Volume Ratio and Visual Bronchiectasis Are Associated With Exacerbations in COPD
di: Nobuyasu Wakazono, et al.
Pubblicazione: (2025)

Epigenetic Scarring and a Vulnerable Mucus–Barrier Axis in Ex‐Smokers With COPD
di: Mitsuo Sato
Pubblicazione: (2026)

Beyond Single Cytokines: Targeting Co‐Receptor CD131 in Asthma‐COPD Overlap
di: Chantal Donovan
Pubblicazione: (2025)

Seeing the Unseen: Cell Population Data Reveal Distinct Inflammatory Phenotypes in Severe COPD
di: Makoto Ishii
Pubblicazione: (2025)

Comment on “High Airway‐to‐Vessel Volume Ratio and Visual Bronchiectasis Are Associated With Exacerbations in COPD ”
di: Junyi Bai, et al.
Pubblicazione: (2025)

Reply to ‘Comment on “High Airway‐to‐Vessel Volume Ratio and Visual Bronchiectasis Are Associated With Exacerbations in COPD ”’
di: Nobuyasu Wakazono, et al.
Pubblicazione: (2025)

Real‐World Evaluation of a Rapid Multiplex PCR Panel in Adults Hospitalized With COPD Exacerbations
di: Charles Wong, et al.
Pubblicazione: (2026)

Is fractional exhaled nitric oxide ready to be a biomarker? Within‐day variability in stable COPD
di: Inès Van Rossem, et al.
Pubblicazione: (2024)

Treatable traits in pre‐COPD: Time to extend the treatable traits paradigm beyond established disease
di: Shyamali C. Dharmage, et al.
Pubblicazione: (2024)

CD131 antagonism blocks inflammation, emphysema and fibrosis in an asthma‐COPD overlap mouse model originating in early life
di: Hao Wang, et al.
Pubblicazione: (2025)

Diffusion capacity and static hyperinflation as markers of disease progression predict 3‐year mortality in COPD: Results from COSYCONET
di: Hendrik Pott, et al.
Pubblicazione: (2024)

Simplifying CPAP Therapy: Is Fixed Pressure the Way Forward?
di: Ahmed S. BaHammam
Pubblicazione: (2025)

Elevated MMP ‐9 Is Associated With Accelerated Lung Function Decline and COPD Development: A Prospective Cohort Study and Mendelian Randomisation Analysis
di: Xinru Ran, et al.
Pubblicazione: (2025)

Correction to “Predictive role of neutrophil‐percentage‐to‐albumin, neutrophil‐to‐lymphocyte and eosinophil‐to‐lymphocyte ratios for mortality in patients with COPD : Evidence from NHANES 2011–2018”
Pubblicazione: (2024)

Benefits of chest wall mobilization on respiratory efficiency and functional exercise capacity in people with severe chronic obstructive pulmonary disease (COPD): A randomized controlled trial
di: Amy Ying Yu Tsui, et al.
Pubblicazione: (2024)

Addressing the Global Challenges of COPD and Asthma: A Shared Vision From the Global Initiative for Chronic Obstructive Pulmonary Disease ( GOLD ) and the Global Initiative for Asthma ( GINA )
di: David M. G. Halpin, et al.
Pubblicazione: (2026)

Letter from Korea—Oral corticosteroid stewardship in Korea: Insights from the Korean Severe Asthma Registry (KoSAR)
di: Noeul Kang, et al.
Pubblicazione: (2024)

Cardiovascular Effect of Snoring in Asians: What Do Biobank and Genomic Studies Say?
di: Shiu Lun Au Yeung, et al.
Pubblicazione: (2025)

Ambient Air Pollution and Risk of ARDS and Mortality in Moderate to Severe COVID ‐19
di: Seohyun Kim, et al.
Pubblicazione: (2026)

Transitional Lung Function Paths in Young Adults: More Opportunities for Prevention?
di: Jennifer L. Perret, et al.
Pubblicazione: (2025)

Tackling a Lifetime of Risk for OSA
di: Neeraj Mukesh Shah, et al.
Pubblicazione: (2025)